Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion

In the absence of an iron chelating agent, patients with beta-thalassemia on regular transfusions present complications of transfusion-related iron overload. Without iron chelation therapy, heart disease is the major cause of death; however, hepatic and endocrine complications also occur. Currently...

Full description

Bibliographic Details
Main Authors: Monica Pinheiro de Almeida Verissimo, Sandra Regina Loggetto, Antonio Fabron Junior, Giorgio Roberto Baldanzi, Nelson Hamerschlak, Juliano Lara Fernandes, Aderson da Silva Araujo, Clarisse Lopes de Castro Lobo, Kleber Yotsumoto Fertrin, Vasilios Antonios Berdoukas, Renzo Galanello
Format: Article
Language:English
Published: Elsevier 2013-01-01
Series:Revista Brasileira de Hematologia e Hemoterapia
Subjects:
Blood transfusion
Chelation therapy
Deferiprone
Deferasirox
Iron/metabolism
beta-Thalassemia
Iron overload
Iron chelating agents
Magnetic resonance imaging
Practice guidelines as topic
Protocols
Brazil
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000600428&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000600428&lng=en&tlng=en

Similar Items